Now Reading: Ant bites to drugs: three allergy cases expose diagnosis gap
-
01
Ant bites to drugs: three allergy cases expose diagnosis gap
In Chennai, a man who had open-heart surgery spent two years on fruitless treatment for rashes caused by an allergic drug reaction, spending up to ₹25,000 a month, until an autorickshaw driver…
In Chennai, a man who had open-heart surgery spent two years on fruitless treatment for rashes caused by an allergic drug reaction, spending up to ₹25,000 a month, until an autorickshaw driver led him to a specialist who simply changed his medicine, costs fell below ₹2,000. A schoolteacher suffered anaphylactic shock from an ant bite, her blood pressure collapsing, but carried a prescription thereafter and was able to treat two later bites before they became severe. A college professor has needed home oxygen since childhood for bronchial allergy she says runs in her family.
Allergy specialist R. Sridharan said reactions are mediated by Immunoglobulin E antibodies that release histamine, dilating blood vessels and potentially causing shock. A 2023 review in the International Journal of Academic Medicine and Pharmacy estimated nearly one in six people in Tamil Nadu may have allergic rhinitis. Doctors said diagnosis is complicated because triggers range from pollen and dust to medications, food and insect venom, and that India needs better awareness and local research on allergy patterns.
Indian Opinion Analysis
This week the WHO published its first-ever list of priority fungal pathogens needing research and surveillance, putting Indian data gaps into sharp relief. India lacks a national allergy registry, meaning prevalence figures are patchy, the 2023 Tamil Nadu study cited exists because researchers crunched old survey data, not fresh clinical reporting. The real burden is almost certainly higher because environmental change, rising humidity in southern cities, longer pollen seasons driven by temperature shifts, is accelerating sensitisation faster than diagnostics can track. The key signal to watch is whether the Union health ministry includes allergy in the next National Family Health Survey or the National Health Profile, which would give the first all-India denominator since the 1960s.
Source: thehindu.com
This brief was synthesised by AI from the source linked above.
